Prof. Martin Götte is a Professor in the Department of Gynaecology and Obstetrics at the University of Münster. His research focuses on extracellular matrix (ECM) components like proteoglycans and their roles in cancer metastasis, microRNA regulation of cell motility, tumor-stroma interactions, and 3D tumor modeling. He leads the Götte Lab, investigating mechanisms of cancer progression using advanced models including organoids and co-culture systems. His work bridges basic science with clinical applications, particularly in ovarian, breast, and endometrial cancers. Key projects include studying Syndecan family proteins' roles in radiation resistance, Musashi RNA-binding proteins' influence on therapy resistance, and TMEM230's impact on glycosylation in cancer and autoimmunity. Research interests span molecular oncology, stem cell biology, and translational medicine. Notable contributions include identifying Syndecan-1 as a prognostic marker in breast cancer and developing 3D models to study invasive growth dynamics. His lab employs single-cell transcriptomics, nanoparticle technology, and in vitro systems to explore ECM-driven cancer mechanisms. Collaborations with the 'Cells in Motion' initiative and the Multiscale Imaging Centre enhance his multidisciplinary approach. Publications emphasize clinical relevance, such as prognostic biomarker discovery and novel therapeutic strategies targeting ECM components or microRNA pathways. He actively participates in research networks addressing endometriosis, adenomyosis, and gynecologic malignancies. Funding sources include grants supporting his lab's innovative cancer modeling and drug delivery systems research.
Dr. Jeanette C. Perron is an Assistant Professor of Pharmaceutical Sciences at the College of Pharmacy and Health Sciences, St. John’s University. She specializes in drug development, biomaterials, and cellular signaling pathways, with a focus on neuropharmacology, immunology, and regenerative medicine. Dr. Perron teaches courses such as BIOCHEMICAL NEUROPHARMACOLOGY, CLINICAL IMMUNOLOGY, and INTRODUCTION TO PHARMACOLOGY. Her research explores innovative drug delivery systems, including nanoemulgel formulations for brain-targeted therapies, as well as therapeutic interventions for neurodegenerative diseases, inflammatory conditions, and cancer. Recent work includes studies on exosome-based therapies for Alzheimer’s disease, benzimidazole compounds for osteogenic differentiation, and GAT107’s role in mitigating ventilator-associated pneumonia. Her publications highlight advancements in understanding BMP (bone morphogenetic protein) signaling mechanisms in spinal neurons, ethanol toxicity mitigation, and quantum dot-conjugated cancer therapies. Dr. Perron’s interdisciplinary approach bridges pharmacology, bioengineering, and molecular biology, contributing to both academic research and clinical applications. She is affiliated with the College’s pharmaceutical and biomedical research initiatives but no specific lab is explicitly listed in the provided information.
Hani Suleiman, M.D., Ph.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center, with a secondary appointment in the Department of Biomedical Engineering. He specializes in nephrology and podocyte biology, focusing on actin cytoskeleton dynamics and glomerular diseases such as FSGS and Minimal Change Disease (MCD). His research employs advanced microscopy techniques like super-resolution imaging (STORM, Airyscan) and novel ex vivo systems to study podocyte structure and function. Education: Medical degree from Damascus University, Ph.D. from the University of Regensburg, and postdoctoral training at Washington University School of Medicine. Prior to UT Southwestern, he held an Assistant Professor position in Nephrology at Washington University (2024). Research Interests: Podocyte actin cytoskeleton regulation, Rho/Rac GTPase balance, extracellular matrix interactions, and development of innovative imaging technologies. His lab investigates mechanisms underlying glomerular diseases using correlative light-electron microscopy and ex vivo podocyte culture models. Lab Innovations: Developed methods for in vivo podocyte imaging, ex vivo hydrogel-cultured podocytes, and volumetric imaging of kidney tissues. These techniques enable unprecedented insights into podocyte mechanics and disease progression.
Stefan Werner is a Privatdozent and Head of Research Group at the Institute of Tumor Biology, part of the Faculty of Medicine at the University of Hamburg. His work focuses on tumor biology, particularly in prostate and breast cancers, with emphasis on circulating tumor cells (CTCs), liquid biopsy applications, and therapeutic targeting strategies. He leads a research group investigating mechanisms of metastasis, tumor dormancy, and resistance to treatment. Key contributions include studies on TROP2 targeting in prostate cancer, HERC5 regulation in lung cancer, and the role of RAI2 in epigenetic suppression. Research interests span oncology, molecular medicine, and translational cancer research. His team employs advanced techniques like nanopore sequencing and molecular imaging to advance precision medicine. Collaborations include work with the Mildred Scheel Cancer Center and the European Liquid Biopsy Society. He is affiliated with the University Cancer Center Hamburg (UCCH) and has published extensively in journals such as Nature Communications , Journal of Clinical Oncology , and Cancer Research . Werner’s research bridges basic science and clinical applications, addressing critical gaps in understanding metastasis and developing novel diagnostic tools. His work highlights the importance of CTC analysis for monitoring tumor recurrence and dormancy states, contributing to personalized cancer care strategies.
Irene Marco Rius is a Junior Group Leader at the Institute for Bioengineering of Catalonia (IBEC) , leading the Molecular Imaging for Precision Medicine group. Her research focuses on developing innovative molecular imaging techniques, particularly hyperpolarized Nuclear Magnetic Resonance (NMR) and Magnetic Resonance Imaging (MRI), to study metabolic pathways in health and disease. She specializes in non-invasive monitoring of cellular metabolism using hyperpolarized probes like [1-13C]pyruvate and lab-on-a-chip systems for high-throughput analysis. Her work integrates principles from bioengineering, chemistry, and physics to tackle challenges in disease biomarker discovery and precision medicine. Key methods include dissolution Dynamic Nuclear Polarization (D-DNP) and Parahydrogen Induced Polarization (PHIP) for hyperpolarization, alongside metabolomics and computational modeling of biological systems. Applications span liver disease, kidney metabolism, and cancer therapy response assessment. Recent advancements include cryopreservation methods for 3D cell culture models and real-time polarimetry using atomic magnetometers. Her lab collaborates on translational projects, aiming to bridge fundamental research with clinical applications. Irene has pioneered techniques for quantifying metabolic changes in vivo, contributing to personalized treatment strategies and early disease detection. Publications highlight her contributions to hyperpolarized MRI methodology, lab-on-a-chip integration with NMR, and biomarker identification in metabolic disorders. Her team’s interdisciplinary approach drives innovation in both instrumentation and biomedical applications, emphasizing open science and collaborative research.
Janny Pineiro is a Research Assistant Professor in the Department of Pharmaceutics at the University of Florida’s Center for Pharmacometrics and Systems Pharmacology. She holds a Ph.D. and M.S. in Biomedical Engineering, and a B.S. in Material Science and Engineering, all from the University of Florida. Her research focuses on biomaterials, tissue engineering, and organ-on-a-chip technologies to advance drug development and precision medicine. She specializes in 3D bioprinting, microphysiological systems, and improving in vitro-in-vivo extrapolation (IVIVE). Dr. Pineiro collaborates with industry, regulatory bodies, and academic institutions, and actively participates in professional societies like SLAS and MPS. Her educational background includes coursework and degrees from the University of Florida, emphasizing interdisciplinary engineering and biomedical applications. She teaches BME3323L Cellular Engineering Laboratory and mentors early-career researchers through programs like the UF Journal of Undergraduate Research and Florida Junior Science Symposia. Her work integrates bioengineering, pharmacology, and computational modeling to address complex biological systems. Publications highlight her contributions to mitochondrial function, extracellular matrix dynamics, and advanced material characterization techniques. She serves as a reviewer for journals such as Frontiers in Pharmacology and ACS Biomaterials Science & Engineering , ensuring rigorous scientific standards. Her lab, based at the Center for Pharmacometrics & Systems Pharmacology in Orlando, focuses on creating physiologically relevant models to enhance drug absorption and metabolism predictions. Collaborations emphasize cross-disciplinary approaches to bridge academia and industry needs.
David W. Sanders is an Assistant Professor at UT Southwestern Medical Center, joining as a tenure-track faculty member in 2023. His research focuses on RNA/protein assemblies in cellular states and their dysregulation in aging-related diseases, particularly neurodegenerative and neuromuscular disorders. He is a member of the Center for Alzheimer’s and Neurodegenerative Diseases. His educational background includes: B.S. in Neurobiology from the University of Kansas (2009) Ph.D. in Neuroscience from Washington University in St. Louis (2016) Postdoctoral training at Princeton University Dr. Sanders' work centers on RNA/protein homeostasis, biomolecular condensates, and phase separation mechanisms in diseases like Alzheimer's and ALS. His lab employs in vitro reconstitution, mammalian cell culture, quantitative microscopy, and genomics to investigate RNA (dys)homeostasis in pathogenesis. He collaborates with Sarah Shahmoradian's structural biology lab, integrating cryo-EM/ET and cryo-CLEM technologies to target neurodegenerative diseases. Analysis of his 15 most recent publications reveals dominant themes in biomolecular condensate biophysics and neurodegenerative disease mechanisms. His work spans fundamental phase separation principles (nucleation, coalescence, thermodynamics) to disease-specific pathways (tau aggregation, stress granule dynamics, viral entry). Key trends include elucidating how pathological protein assemblies form and propagate, with direct therapeutic implications for tauopathies and ALS. No scientific awards are mentioned in the provided text. The Sanders Lab emphasizes curiosity-driven research without formal student listings in the provided materials. Their philosophy advocates rigorous hypothesis testing independent of past successes, embracing risk and open collaboration. Grant details are not specified, but the lab actively recruits researchers who share their passion for destroying dogma in neurodegenerative disease research. The Sanders Lab (dubbed 'Shahmoranders') operates at UT Southwestern with a focus on RNA/protein aggregation models. Their collaborative framework with the Shahmoradian Lab combines cell biology approaches with advanced structural techniques to combat neurodegenerative and neuromuscular diseases. The lab culture prioritizes insatiable curiosity, transparent communication, and methodological flexibility to overcome scientific roadblocks.
Prof Gary Hutchison is the Dean of the School of Applied Sciences at Edinburgh Napier University and a member of the University Senior Leadership Team. He holds advanced degrees in Molecular and Cell Biology (BSc, University of Stirling), Drug Design and Biomedical Science (MSc), and a PhD in Nanotoxicology from Napier University. His research focuses on nanomaterial safety, particularly their interactions with human systems and environmental impacts. He leads projects like the EU-funded BIORIMA and MARINA initiatives, addressing risk management of nanomaterials in medical applications. Prof Hutchison serves on UK government advisory committees, including the FSA Committee on Toxicity and Defra’s College of Scientific Experts. He chairs the Scottish Institute for Policing Research Board and contributes to STEM/STEAM education initiatives through the Scottish Council of Deans for Education. His work spans nanomaterial toxicity in reproductive health, pollutant interactions, and environmental sustainability strategies. He has secured significant grants for collaborative studies, including the £158,070 BIORIMA project. His advisory roles emphasize policy development for sustainable chemicals and nanotechnology governance. His research teams investigate in vitro models for nanomedicine safety and host defense mechanisms against nanoparticles.
Alexander Khmaladze serves as an Associate Professor in the Department of Physics at the University at Albany, where he develops advanced optical imaging methodologies for biological research. His academic credentials: PhD in Applied Physics, University of South Florida (2008) Postdoctoral Researcher, University of Michigan (2008-2013) Research concentrates on non-invasive optical techniques for live biological specimens, emphasizing multimodal integration of Raman spectroscopy, 3D digital holographic imaging, custom microscope design, and hyperspectral analysis. His work enables in-vitro and in-vivo observation of dynamic cellular processes under near-natural conditions, bridging physics and biomedical applications through innovative instrumentation. He directs the µ BioLab, which pioneers optical imaging systems for cellular and tissue analysis. No scientific awards were documented in source materials. No information regarding student mentorship or research funding was provided.
Jon Romero Aguirregomezcorta is an Assistant Professor at the University of Murcia’s Faculty of Veterinary Medicine, affiliated with the Department of Anatomy and Pathological Anatomy in Veterinary Medicine. He holds a PhD from the University of Murcia (2015), focusing on porcine gamete interaction mechanisms involving oviductal fluid, α-L-fucosidase, and nitric oxide. His research emphasizes reproductive physiology in domestic animals, particularly pigs and cattle, with a focus on optimizing in vitro fertilization (IVF), embryo development, and assisted reproductive technologies (ART). Key research areas include oviductal fluid’s role in gamete interaction, sperm functionality regulation, and the application of biotechnologies like 3D-printed scaffolds for embryo culture. His work bridges veterinary medicine and reproductive biology, addressing challenges in livestock production and conservation of endangered breeds. Recent studies explore epigenetic modifications in oocytes, metabolic profiles of ART-derived animals, and novel diagnostic techniques for sperm quality. His articles highlight advancements in IVF protocols, including the use of extracellular vesicles and optimized culture media. Notably, he investigates long-term physiological outcomes of ART in cattle and pigs, contributing to both academic and applied veterinary science. Romero Aguirregomezcorta collaborates with the Physiology of Reproduction research group, focusing on translating biological insights into practical applications for animal husbandry and conservation.
Robert L. Steward Jr. is an Associate Professor in the Department of Mechanical and Aerospace Engineering at the University of Central Florida (UCF). He leads the Cellular Biomechanics Lab at UCF's Health Science Campus at Lake Nona, focusing on linking mechanics and medicine through interdisciplinary research. His work explores cellular responses to mechanical forces in contexts like cardiovascular disease, diabetes, and neuroscience. Education: Ph.D. in Mechanical Engineering, Carnegie Mellon University Bachelor of Science in Mechanical Engineering, Clark Atlanta University Research Interests: His research integrates biomechanics, mechanotransduction, and biomedical engineering to understand how cells respond to mechanical stimuli such as fluid shear stress and substrate stiffness. Key areas include endothelial cell mechanics, tumor microenvironment modeling, and bio-inspired medical devices. Recent work emphasizes predicting cellular mechanosensation using machine learning and developing lab-on-a-chip systems for cardiovascular studies. Publications: His articles highlight advancements in understanding fluid dynamics' effects on endothelial cells, 3D scaffold applications for cancer research, and open-source biomedical devices. Notable trends include mechanotransduction modeling, extracellular matrix interactions, and translational biomedical engineering solutions. Awards: NIH Mentored Quantitative Research Development Award (K25) Grants & Labs: Steward's lab at Lake Nona focuses on translational projects bridging engineering and medicine. Collaborations involve developing biomaterials for disease modeling and diagnostic tools. His NIH-funded research explores predictive models of cellular mechanical responses to chemical perturbations.
Samet Kocabey is a Senior Researcher at the University of Fribourg's Faculty of Science and Medicine, affiliated with the AMI - Soft Matter Physics group. His work focuses on developing innovative biosensors, nanomaterials, and biomaterials for biomedical applications, particularly in cancer diagnostics and regenerative medicine. He holds a PhD in Biomedical Engineering (2016) from Ludwig-Maximilians-Universität München and an earlier thesis on peptide nanofibers for bone regeneration (2012). His research integrates nanotechnology, molecular biology, and cellular mechanisms to advance diagnostic tools and therapeutic strategies. Research Interests : Development of DNA-based biosensors for cancer biomarker detection Nanostructured materials for drug delivery and anti-inflammatory therapies Biomimetic peptide nanofibers for bone tissue engineering Membrane interactions of DNA nanostructures Key Publications : Recent work includes ultrasensitive cancer nucleic acid detection systems (2025), smartphone-based microscopy (2024), and DNA origami biosensors (2022). His research has been published in Biosensors and Bioelectronics , Nano Today , and Biomaterials . Grants & Collaboration : Active in interdisciplinary projects combining physics, biology, and engineering. Collaborates with institutions in Europe on biomaterials and diagnostics. Labs & Affiliations : Part of the AMI group and affiliated with the Institute of Medical Fundamental Research (IMF) and the Nanotechnology Research Alliance (NARA).
Michael Davies is a Professor at the Department of Biomedical Sciences, Panum Institute, University of Copenhagen (2014–present). Previously held leadership roles including Director of The Heart Research Institute (Sydney, Australia, 2012–2014) and Conjoint Professor at the University of Sydney (2004–2014). His research focuses on protein oxidation, myeloperoxidase activity, and their roles in atherosclerosis, inflammation, and cardiovascular diseases. A globally recognized scholar with over 430 peer-reviewed publications and an H-index of 102 (Google Scholar). Key Positions: Professor, University of Copenhagen (2014–present) Director, The Heart Research Institute (2012–2014) Australian Research Council Professorial Fellow (2009–2013) Research Interests: Davies’ work bridges biochemistry and medicine, emphasizing radical-mediated protein oxidation, extracellular matrix modification, and myeloperoxidase-driven inflammation. His studies investigate how oxidative stress contributes to chronic diseases like atherosclerosis, leveraging proteomics and advanced analytical techniques. Honors & Awards: Novo Nordisk Laureate Award (2014–2020) Europe Award, Society for Free Radical Research (2017) Lifetime Achievement Award, SFRR-India (2014) Advising & Grants: Davies has led major research initiatives, including ARC Fellowships and international collaborations. His lab focuses on translational research, developing in vitro models like cardiac spheroids for heart microenvironment studies.
Dr. Faheem Ershad is an Assistant Professor in the Department of Electrical & Computer Engineering at the University of Houston, affiliated with the College of Engineering. His research focuses on soft bioelectronic systems integrating wearable/implantable devices with tissues, leveraging 3D biofabrication, optoelectronics, and machine learning. He leads the bioelectronic Synergy Lab, emphasizing interdisciplinary approaches to cardiac health and neural modulation. Education: B.S. (Biomedical Engineering, UH), Ph.D. (Biomedical Engineering, Penn State), Postdoc (UIUC) Lab: bioelectronic Synergy Lab – develops hybrid bioelectronic-tissue systems for diagnostics and therapy Key Research Areas: Stretchable bioelectronics, tissue integration, ambulatory biosensors, electrophysiology His work bridges electrical engineering, materials science, and medicine, with recent innovations in drawn-on-skin sensors, rubbery semiconductor electronics, and bioprinted cardiac tissues. Over 20 peer-reviewed articles showcase advancements in soft electronics for healthcare applications. Notable Awards: NSF Career Award Editorial Contributions: Guest Editor for Biosensors special issue Current projects include developing customizable wearable devices and exploring machine learning-driven bioelectronic interfaces. The lab actively collaborates with industry through its NSF-funded programs and maintains a strong focus on translational research.
Daniel Pack is a Professor of Chemical and Materials Engineering and Pharmaceutical Sciences at the University of Kentucky, holding the Ashland Inc. Chair in Chemical Engineering since 2012. His research focuses on the design and development of advanced drug and nucleic acid delivery systems through elucidation of intracellular biomaterial processing mechanisms, with applications in human gene therapy for disease prevention and treatment. His educational background includes: Ph.D. in Chemical Engineering, California Institute of Technology (1997) B.S. in Chemical Engineering (summa cum laude), University of Illinois, Urbana-Champaign (1990) Professor Pack's research centers on drug delivery and gene therapy , with emphasis on non-viral vectors like polyethylenimine (PEI). His work investigates chemical modifications (acetylation, succinylation) to overcome serum instability and intracellular barriers, enabling efficient nucleic acid delivery. Key applications include cancer therapy, CRISPR/Cas9 delivery, and biosynthesis of therapeutic compounds in mammalian cells. His approach integrates fundamental biomaterials science with translational biomedical engineering to address critical challenges in therapeutic efficacy. Analysis of his 15 most recent publications reveals sustained innovation in PEI-based polyplex engineering, with dominant themes in chemical modification strategies for enhanced serum stability, receptor-targeted delivery systems (particularly folate-mediated), and expansion into CRISPR/Cas9 applications. His work consistently bridges fundamental structure-function relationships with therapeutic outcomes, while recent publications demonstrate growing integration of biosynthetic approaches for natural product production in mammalian cells. His scientific awards include: 2008 Xerox Award for Faculty Research, College of Engineering, University of Illinois, Urbana-Champaign 2007 Multi-Year Faculty Achievement Award, College of Engineering, University of Illinois, Urbana-Champaign 2007 Engineering Council Award for Excellence in Advising, University of Illinois, Urbana-Champaign 2006 Alumni Discretionary Award, College of Liberal Arts and Sciences, University of Illinois, Urbana-Champaign 2006 Engineering Council Award for Excellence in Advising, University of Illinois, Urbana-Champaign 2004-2005 Beckman Fellow, Center for Advanced Study, University of Illinois, Urbana-Champaign 2004 Controlled Release Society/Genencor Outstanding Consumer & Diversified Products Paper Award 2003-2006 3M Young Faculty Award 2003 Excellence in Teaching Award, School of Chemical Sciences, University of Illinois, Urbana-Champaign 2002-2007 Faculty Early Career Development (CAREER) Award, National Science Foundation 2000 Incomplete List of Teachers Ranked as Excellent by Their Students, Fall 2000, University of Illinois, Urbana-Champaign 2000 Excellence in Teaching Award, School of Chemical Sciences, University of Illinois, Urbana-Champaign 2000 Collins Scholar, Academy for Excellence in Engineering Education, University of Illinois, Urbana-Champaign 1997-1999 National Institutes of Health Post-doctoral Fellowship, Massachusetts Institute of Technology 1996 Distinguished Graduate Student Lectureship, California Institute of Technology 1995 Materials Research Society Graduate Student Award 1991-1994 Landau Fellowship, California Institute of Technology 1990 University Scholar, University of Illinois 1990 Senior Alumni Award (Chemical Engineering), University of Illinois Professor Pack has demonstrated exceptional commitment to student mentorship, evidenced by multiple Engineering Council Awards for Excellence in Advising (2006, 2007). His research has been substantially supported by competitive grants including the NSF CAREER Award (2002-2007) and 3M Young Faculty Award (2003-2006), with funding spanning biomaterials engineering, gene delivery mechanisms, and therapeutic applications. His interdisciplinary collaborations extend across pharmaceutical sciences and biomedical engineering. His laboratory at the University of Kentucky pioneers the development of next-generation delivery platforms, currently focusing on hybrid polymer/nanoceria systems for combined gene and antioxidant therapy, chemically modified polyplexes for CRISPR/Cas9 applications, and engineered mammalian cell factories for natural product biosynthesis. The team maintains strong translational focus through partnerships with clinical researchers for oncology applications and regenerative medicine.
